One-fifth of pharmaceutical industry payments are made to non-prescribing healthcare professionals such as nurses and pharmacists, a new review reveals. According to the authors from the University of Sydney’s Evidence, Policy and Influence Collaborative at the Charles Perkins Centre, the findings raise questions around influence and identify a need for greater transparency. “In contrast to ...
Already a member?
Enter your email to keep reading.